IQV

IQV

USD

IQVIA Holdings Inc. Common Stock

$211.410+0.550 (0.261%)

실시간 가격

Healthcare
Diagnostics & Research
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$210.860

고가

$215.940

저가

$209.090

거래량

1.49M

기업 기본 정보

시가총액

36.0B

산업

Diagnostics & Research

국가

United States

거래 통계

평균 거래량

1.44M

거래소

NYQ

통화

USD

52주 범위

저가 $134.65현재가 $211.410고가 $225.91

AI 분석 리포트

마지막 업데이트: 2025년 11월 1일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

IQVIA Holdings (IQV): Riding a Wave of Analyst Upgrades After a Monumental Price Surge

November 1, 2025, 10:56 AM EDT

The Analyst Drumbeat: A Chorus of Confidence Lifts IQV

The story surrounding IQVIA in late October became incredibly clear and loud. On a single day, October 29th, a torrent of positive revisions came from Wall Street's top analysts. It wasn't just one or two voices; it was a powerful consensus. Baird upgraded the stock from Neutral to Outperform. Heavyweights like JP Morgan, UBS, Stifel, and Truist Securities all reiterated their bullish stances while substantially raising their price targets.

Here's a quick look at the new targets:

  • Citigroup: Raised to $230
  • UBS: Raised to $250
  • Stifel: Raised to $254
  • JP Morgan: Raised to $255
  • Baird: Raised to $258
  • Truist Securities: Raised to $265

This unified vote of confidence from the analyst community is a significant event. It suggests that recent performance or forward guidance has fundamentally shifted their perception of the company's value, creating a powerful narrative that has clearly caught the market's attention.

From Sideways Chop to a Vertical Leap: Decoding IQV's October Breakout

Looking at IQVIA's stock chart over the last three months tells a tale of two distinct periods. August and September were characterized by choppy, sideways trading, with the stock struggling to find direction and bouncing between roughly $176 and $193. There was no real conviction.

Then October arrived.

The first day of the month saw the stock explode, gapping up from around $190 to over $203 on massive volume. This wasn't a gradual climb; it was a definitive statement from buyers. After consolidating those gains for a few weeks, another powerful surge began around October 20th, launching the stock from the mid-$200s to a peak of $225. The price has since settled around the $216 level. This pattern--a sharp breakout on heavy volume followed by consolidation--is a classic sign of strength and renewed market interest. The stock has built a new, higher foundation.

The Digital Crystal Ball: What AI Sees for IQV's Next Move

The current momentum is not just visible on the chart; it's also being confirmed by predictive models. An AI forecast projects continued strength in the immediate future, with anticipated gains of 1.64%, 2.77%, and 3.23% over the next three trading days. The model shows high confidence in this upward trend, projecting a potential target price near $229.71.

This bullish short-term outlook, however, runs into a notable headwind: the company's fundamentals. While technical signals and news sentiment are flashing green, the company carries a high debt-to-equity ratio of over 240%. This is a significant long-term risk factor. The situation presents a classic conflict for investors--powerful, news-driven momentum versus underlying financial leverage that cannot be ignored.

The Bottom Line

For now, momentum is in the driver's seat for IQV. The combination of a technical breakout, a tidal wave of positive analyst ratings, and supportive AI predictions creates a compelling case for a short-term trade. This is not a "buy and hold forever" scenario, especially given the high debt load. Instead, it appears to be an opportunity for nimble traders looking to ride the current wave of positive sentiment.

A strategic approach could involve considering entry points around the current price levels of $216 to $217. The data suggests a clear profit target near $228.75, just shy of the AI's projection. To manage risk, a stop-loss order around $194.81 would protect against a sudden reversal that erases the recent breakout gains. This strategy is best suited for an investor with a short-term horizon of one to two weeks who is comfortable acting on clear momentum signals while respecting defined risk parameters.


Disclaimer: This report is for informational purposes only and does not constitute financial, investment, or trading advice. The analysis is based solely on the data provided and is not a guarantee of future performance. All investing involves risk, including the possible loss of principal. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

관련 뉴스

Analyst Upgrades

TD Cowen Downgrades IQVIA Hldgs to Hold, Raises Price Target to $215

TD Cowen analyst Charles Rhyee downgrades IQVIA Hldgs from Buy to Hold and raises the price target from $206 to $215.

더 보기
TD Cowen Downgrades IQVIA Hldgs to Hold, Raises Price Target to $215
Analyst Upgrades

Citigroup Maintains Neutral on IQVIA Hldgs, Raises Price Target to $230

Citigroup analyst Patrick Donnelly maintains IQVIA Hldgs with a Neutral and raises the price target from $200 to $230.

더 보기
Citigroup Maintains Neutral on IQVIA Hldgs, Raises Price Target to $230
Analyst Upgrades

UBS Maintains Buy on IQVIA Hldgs, Raises Price Target to $250

UBS analyst Dan Leonard maintains IQVIA Hldgs with a Buy and raises the price target from $225 to $250.

더 보기
UBS Maintains Buy on IQVIA Hldgs, Raises Price Target to $250
Analyst Upgrades

Stifel Maintains Buy on IQVIA Hldgs, Raises Price Target to $254

Stifel analyst Shlomo Rosenbaum maintains IQVIA Hldgs with a Buy and raises the price target from $234 to $254.

더 보기
Stifel Maintains Buy on IQVIA Hldgs, Raises Price Target to $254
Analyst Upgrades

JP Morgan Maintains Overweight on IQVIA Hldgs, Raises Price Target to $255

JP Morgan analyst Casey Woodring maintains IQVIA Hldgs with a Overweight and raises the price target from $177 to $255.

더 보기
JP Morgan Maintains Overweight on IQVIA Hldgs, Raises Price Target to $255
Analyst Upgrades

Truist Securities Reiterates Buy on IQVIA Hldgs, Raises Price Target to $265

Truist Securities analyst Jailendra Singh reiterates IQVIA Hldgs with a Buy and raises the price target from $235 to $265.

Analyst Upgrades

Baird Upgrades IQVIA Hldgs to Outperform, Raises Price Target to $258

Baird analyst Eric Coldwell upgrades IQVIA Hldgs from Neutral to Outperform and raises the price target from $224 to $258.

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 11월 4일 오후 08:52

약세중립강세

74.8% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
보수적
트레이딩 가이드

진입점

$215.57

익절

$228.72

손절

$194.81

핵심 요소

PDI 6.4이(가) ADX 18.1과 함께 MDI 4.0 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($215.28)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(18,638)의 7.4배로 극도로 강력한 매수 압력을 나타냅니다.
MACD 0.2504이(가) 신호선 0.1889 위에 있어 강세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기